Dexamethasone Phosphate

• A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post COVID-1… Not authorised
  2023-504087-42-00 Phase III 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
• Efficacy of intravenous dexamethasone in prolonging the duration of spinal anesthesia with chloroprocaine in knee arthroscopy. Pending
  2023-505247-39-00 Phase III 1 country Centre Medico Chirurgical Ambroise Pare Hartmann
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 Phase III 11 countries Charite Universitaetsmedizin Berlin KöR
• ESP-BACK : Erector Spinae Plane Block for acute low back pain Pending
  2024-511595-32-00 Phase IV 1 country Centre Hospitalier Universitaire De Montpellier
• A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending
  2024-519504-27-00 Phase III 10 countries Regeneron Pharmaceuticals Inc.
• CYPENZA - A prospective cohort trial on antiandrogens influences on the pharmacokinetics of corticosteroids. Pending
  2025-520571-66-00 Phase III 1 country Region Vaesterbotten
• Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE) Pending
  2026-525263-41-00 Phase III 1 country Polska Grupa Badawcza Chloniakow
• Dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international … Recruiting
  2023-508153-12-00 Phase III 4 countries Centre Hospitalier Universitaire De Nantes
• Effect of nepafenac/dexamethasone fixed dose combination vs. its individual components (nepafenac and dexamethasone monotherapies) on postop… Recruiting
  2025-523367-38-00 Phase III 1 country Medivis S.r.l.
• Evaluation of postoperative recovery when combining intravenous lidocaine with ropivacaine infiltration in laparoscopic colorectal oncologic… Recruiting
  2025-523207-29-00 Phase IV 1 country Centre Hospitalier Universitaire Amiens Picardie
• Anesthetic block of the erector muscles of the lumbar spine to relieve acute lumbar pain: pilot study Recruiting
  2024-511818-21-00 Phase III 1 country Sante Atlantique
• A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution… Recruiting
  2025-522291-83-00 Phase III 2 countries Dompe' Farmaceutici S.p.A.
• Effect of early dexamethasone on major complications and all-cause mortality in severe burns Recruiting
  2024-517708-12-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
• Corticosteroids before extubation in pediatric intensive care unit: a prospective randomized double-blind multicenter study Recruiting
  2023-504829-39-00 Phase III 1 country Assistance Publique Hopitaux De Paris
• Comparing postoperative recovery after vitrectomy using NSAID eyedrops versus steroid eyedrops Recruiting
  2024-518807-23-00 Phase IV 1 country UZ Leuven
• Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with … Recruiting
  2024-518316-39-00 Phase II/III 1 country Medical University Of Lodz
• Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular p… Recruiting
  2024-517441-14-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Rennes
• Avoid With locoregional Analgesia Persistant Postoperative Pain After Surgery In Children Recruiting
  2023-503499-25-00 Phase IV 1 country Centre Hospitalier Universitaire De Nantes
• Akynzeo as antiemetic treatment in patients with endometrial cancer treated with taxane - platinum combination chemotherapy. NOEME study. Recruiting
  2023-504150-35-00 Phase IV 1 country Fondazione IRCCS Istituto Nazionale Dei Tumori
• Phase 1/2 study of mRNA-3705 in participants with Isolated MMA (Extension Study). Recruiting
  2022-501997-20-00 Phase I (FiH) 3 countries Moderna Inc.
• Tebentafusp Regimen Versus Investigator’s Choice in Previously Treated Advanced Melanoma (TEBE-AM) Recruiting
  2022-502732-39-00 Phase II/III 7 countries Immunocore Limited
• First-line combination of Bcl-2 inhibitor and monoclonal antibody followed by administration of Bcl-2 inhibitor alone or combination of Bcl-… Recruiting
  2023-510431-11-00 Phase II 1 country Fondazione Gimema Franco Mandelli Onlus
• Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy. (SNAP) Ended
  2025-523957-32-00 Phase IV 1 country Rigshospitalet
• Phase II proof-of-concept, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of plitidepsin in adults w… Ended
  2024-516378-31-00 Phase II 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…

Showing 1–24 of 36 trials